[The effect of liposomal form of L-Dopa on the level of dopamine, its metabolites, and phospholipid metabolism in the striatum of mice with experimental parkinsonian syndrome].
Iurasov
V V
VV
Podgornyĭ
G I
GI
Kucherianu
V G
VG
Kudrin
V S
VS
Nikushkin
E V
EV
Zhigal'tsev
I V
IV
Sandalov
Iu G
IuG
Kaplun
A P
AP
Shvets
V I
VI
Kryzhanovskiĭ
G N
GN
D000818:Animals; D001812:Blood-Brain Barrier; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D007980:Levodopa / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008081:Liposomes; D020267:MPTP Poisoning; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism*
D015259:Dopamine Agents; D008081:Liposomes; D010743:Phospholipids; D007980:Levodopa; D004298:Dopamine